Related references
Note: Only part of the references are listed.Bcl-2-Protein Family as Modulators of IP3 Receptors and Other Organellar Ca2+ Channels
Hristina Ivanova et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
Adrien Nougarede et al.
CANCER RESEARCH (2018)
Bcl-2 on the brink of breakthroughs in cancer treatment
John C. Reed
CELL DEATH AND DIFFERENTIATION (2018)
Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
In Hee Lee et al.
MEDICAL ONCOLOGY (2018)
Redox regulation of EGFR steers migration of hypoxic mammary cells towards oxygen
Mathieu Deygas et al.
NATURE COMMUNICATIONS (2018)
BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy
Adrien Nougarède et al.
Oncotarget (2018)
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Nikolay Popgeorgiev et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo
Yun Bai et al.
MOLECULAR CARCINOGENESIS (2017)
Non-apoptotic functions of BCL-2 family proteins
Atan Gross et al.
CELL DEATH AND DIFFERENTIATION (2017)
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
Mohamed-Amine Hamouda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
BH4 domain of Bcl-2 as a novel target for cancer therapy
Zhiqing Liu et al.
DRUG DISCOVERY TODAY (2015)
BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
Thomas Cluzeau et al.
Oncotarget (2015)
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes
Emiliano Fabiani et al.
LEUKEMIA & LYMPHOMA (2014)
Non-apoptotic roles of Bcl-2 family: The calcium connection
Benjamin Bonneau et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Taxol Directly Induces Endoplasmic Reticulum-Associated Calcium Changes That Promote Apoptosis in Breast Cancer Cells
Zhi Pan et al.
BREAST JOURNAL (2011)
BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells
Jing Da Xu et al.
JOURNAL OF PATHOLOGY (2011)
Bcl-2 family on guard at the ER
Eva Szegezdi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma
Frederic Luciano et al.
BLOOD (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members
SA Oakes et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Characterization of NR13-related human cell death regulator, Boo/Diva, in normal and cancer tissues
RM Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Nrh, a human homologue of Nr-13 associates with Bcl-Xs and is an inhibitor of apoptosis
A Aouacheria et al.
ONCOGENE (2001)
Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak
N Ke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
